Director sold ~$7.05M of Palantir
Scheduled in advanceTraded Feb 2, 2026 · Filed Feb 5, 2026
Sold under a plan set up in advance, so the timing wasn't a fresh decision
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$106,166
Shares × reported transaction price
on the day of results (Feb 2, 2026), 91 days before results of May 4, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $147.76 on Feb 2, 2026, 100% above its 52-week low and 29% below its high, after a 17% drop over the previous 30 trading days
52-week range $74.01 (Apr 4, 2025) to $207.18 (Nov 3, 2025), 55% of the way up, from 251 adjusted closes. 30 trading days earlier: $177.29 on Dec 17, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -0.7% | +0.5% | -1.2% |
| 30 days | +20.3% | +0.1% | +20.2% |
| 90 days | +2.9% | +8.3% | -5.4% |
| 180 days | +25.1% | +13.8% | +11.3% |
Past results only. Not a forecast.
Director sold ~$7.05M of Palantir
Scheduled in advanceDirector sold ~$6.64M of Palantir
Scheduled in advanceDirector sold ~$31.9M of Palantir
Scheduled in advance